When the opsonization of various Pseudomonas aeruginosa strains-PAC 1, its O-chain-deficient mutant PAC 605, and an intermediate strain, P14-was measured either directly by determination of the amount of C3b attached to the bacterial surface or indirectly by assessing phagocytosis by human polymorphonuclear leukocytes and the responses of chemiluminescence, it was demonstrated that PAC 1 was opsonized and phagocytized to a lower extent than P14 and PAC 605. In contrast to PAC 605, PAC 1 showed an increased consumption of complement in the fluid phase and a rapid release of lipopolysaccharide antibodies bound to the bacterial surface due to the alternative pathway of the complement system. Furthermore, it was shown that with respect to PAC 1 and PAC 605, the lack of an 0-chain resulted in increased sensitivity to serum and decreased virulence. From both in vivo and in vitro experiments, we concluded that the structure of the 0-antigen polysaccharide chain of lipopolysaccharide is an important virulence factor of P. aeruginosa against the defense mechanisms of the host.
One of the most important biological functions of the serum complement system is its role in bacterial opsonization. Moreover, phagocytic cells appear to possess receptors for the activated fragment of the third component of complement (C3b) bound to the bacterial surface (20) . Normal human serum is opsonic for most clinical isolates of Pseudomonas aeruginosa, and opsonization of these isolates is mediated by complement. Although some P. aeruginosa strains can be opsonized by complement in a relatively low concentration of antibodies, the so-called "natural" antibodies appear to initiate the complement-mediated opsonization of most strains. As a consequence, immunoglobulin and complement deficiency predispose for infections with P. aeruginosa (4, 5, 33, 37, 38, 48) .
In general, P. aeruginosa is effectively opsonized with C3b by the classical complement pathway and to a lesser extent by the alternative pathway (33, 37) . In our experiments, we observed various strains of P. aeruginosa that were not well opsonized in normal human serum, and consequently these strains were poorly phagocytized by human polymorphonuclear cells (PMNs) . Surprisingly, these strains showed a considerably higher complement consumption than did strains that were well opsonized and phagocytized. The aim of the present study was to investigate the underlying mechanism of this phenomenon with P. aeruginosa strains PAC 1, its 0-chain-deficient mutant PAC 605, and an intermediate, P14.
MATERIALS AND METHODS
Organisms and cultural conditions. P. aeruginosa strains PAO 1, PAC 1, and PAC 605 (0-chain-deficient spontaneous mutant of PAC 1) were provided by P. M. Meadow, Biochemistry Department, University College, London. P. aeruginosa P14 was obtained from P. C. J. Leijh, Department of Infectious Diseases, University Hospital, Leiden, The Netherlands. Staphylococcus aureus 104 was provided by J. P. Soulier, Centre National de Transfusion Sanguine, Paris. Escherichia coli F8 was provided by J. Verhoef, * Corresponding author.
Department of Microbiology, University of Utrecht, The Netherlands. Stock cultures were maintained on nutrient agar slants at 4°C and were subcultured monthly. The strains were grown overnight at 37°C in Trypticase soy broth (BBL Microbiology Systems, Cockeysville, Md.) and were subcultured by a 1-in-10 inoculum in Trypticase soy broth. After 1 h of growth at 37°C, the cultures were centrifuged for 15 min at 10,000 x g and the bacteria were washed three times in phosphate-buffered saline (PBS) (pH 7.4) supplemented with 5 mM MgCl2, and adjusted to a final bacterial concentration of 2.5 x 108 cells per ml with a Petroff-Hausser counting chamber.
Opsonins. Normal human serum from 10 healthy donors was pooled and stored in 0.5-ml aliquots at -70°C. Shortly before use, the aliquots were thawed and diluted to the desired concentration in Hanks balanced salt solution containing 0.1% gelatin. For study of opsonization in the absence of the classical complement pathway, undiluted serum was chelated with magnesium ethyleneglycol-bis(paminoethyl ether)-N,N,N',N'-tetraacetic acid (Mg EGTA; final concentration, 10 mM) as described by Forsgren and Quie (10) . Treatment of the serum with Mg EGTA revealed a complete loss of CH50, whereas the AP50 had decreased less than 5%. Opsonization in the absence of both complement pathways was performed in serum chelated with EDTA at a final concentration of 10 mM. Sera depleted of specific immunoglobulins were prepared by absorption of normal human serum (20%) twice with 5 x 109 washed bacteria per ml at 4°C for 60 min. Enzyme-linked immunosorbent assay techniques demonstrated that the titers of natural antibodies (immunoglobulin G [IgG] as well as IgM) against P. aeruginosa in absorbed serum had been reduced more than 20-fold as compared with those in nonabsorbed serum. On the contrary, the complement content was hardly affected by this treatment as indicated by a less than 10% decrease in CH50 and AP50. Heat-inactivated serum was prepared by heating thawed samples of serum at 56°C for 30 min.
Opsonization of bacteria. In plastic tubes (12 by 75 mm; Falcon Plastics, Oxnard, Calif.), 0.2 ml of each bacterial suspension (containing 5 x 108 cells per ml) and 0.8 ml of COMPLEMENT ACTIVATION BY PSEUDOMONAS AERUGINOSA serum (20% [vol/vol] ) were incubated at 37°C for 30 min. The serum was removed by centrifugation (15 min at 1,600 x g), and the opsonized bacteria were resuspended in Hanks balanced salt solution to a final concentration of 5 x 107 cells per ml.
Measurement of C3 fixation. The amount of C3 attached to opsonized, washed bacteria was quantitatively measured in a spectrophotometrical immunoassay. At various times the process of opsonization was stopped by the addition of 3 ml of ice-cold PBS plus 2.5 mM MgCl2 to the incubation vial.
The bacteria were washed three times with ice-cold PBS-MgCl2 and resuspended in 1 ml of PBS-MgCl2. Then 100 ,ul of bacterial suspension was incubated with 100 p1l of peroxidase-conjugated goat antiserum (1:50 diluted with PBS-1% bovine serum albumin [PBS-BSA]) specific for human C3 (Cappel Laboratories, West Chester, Pa.). To avoid aspecific binding of the conjugate to the vessel wall, the vials were preincubated with PBS-BSA for 1 h at room temperature. After 15 min of incubation at 25°C, 1.8 ml of ice-cold PBS-BSA was added and the bacteria were washed three times with PBS-MgCl2 supplemented with 1% BSA to remove nonreacted conjugate. Finally, the bacteria were suspended in 1 ml of PBS-MgCl2. Peroxidase (POD) activity was measured in Eppendorf vials by the method of Wolters et al. (47) . To 250 ,I of bacterial suspension, 500 ,ul of freshly prepared reagent containing (per 10 ml) 4 mg of ophenylenediamine (Sigma Chemical Co., St. Louis, Mo.), 9 ml of PBS, and 1 ml of 0.15% H202 were added. After 20 min of incubation at 30°C in the dark, the reaction was stopped with 250 p.l of 2 M sulfuric acid and the absorbance was measured spectrophotometrically at 492 nm. The number of bacteria in the peroxidase assay was determined microscopically in a Petroff-Hausser counting chamber. The results are given in absorption units per 107 bacteria.
Leukocytes. Blood samples from healthy volunteers were collected in heparinized syringes (10 U/ml of blood). PMNs were prepared by dextran sedimentation and centrifugation over a Ficoll-Paque gradient (Pharmacia, Uppsala, Sweden) by the method of Verbrugh et al. (44) . The PMNs were suspended in Hanks balanced salt solution containing 0.2% gelatin, and the final suspension was adjusted to a concentration of 5 x 106 PMNs per ml. The PMN preparations demonstrated 95 to 97% viability as measured by trypan blue exclusion.
Determination of phagocytosis. A 0.2-ml sample of the leukocyte suspension was added to 0.2 ml of the opsonized bacterial suspension in polypropylene vials (Biovials; Beckman Instruments, Inc., Schiller Park, Ill.). The final bacteriato-phagocyte ratio was 10:1. The mixtures were shaken at 150 rpm at an angle of 300 in a water bath at 37°C for 30 min. Phagocytosis was stopped by the addition of 2.5 ml of ice-cold PBS. After centrifugation (150 x g for 5 min at 4°C), leukocyte pellets were washed three times with ice-cold PBS to remove non-leukocyte-associated bacteria. Phagocytosis was assessed morphologically by the cover slip method as described by Van Furth et al. (43) by examination of 100 PMNs and was calculated by the following formula of Hammer et al. (16) : [mean number of ingested bacteria per PMN x (total number of PMNs)/(total number of added bacteria)] x 100.
Chemiluminescence assay procedure. All chemiluminescence (CL) measurements were performed with a Biocounter M2010 (Lumac-3M, Schaesberg, The Netherlands). To each cuvette were added 100 RI1 of opsonized bacteria (4 x 107 per ml), 100 ,u1 of PMNs (2.7 x 106 cells), and 100,ul of luminol (10-6 M). The PMNs and luminol were preincubated at 37°C for 10 min before the addition of the prewarmed microorganism suspension. CL measurements were made for 10 s every 2.5 min over a 25-min period. Between the measurements, the incubation tubes were incubated and shaken at 37°C.
Complement. The total hemolytic complement (CH50) of serum and the consumption of complement in the incubation mixtures were assayed with optimally sensitized sheep erythrocytes by the method of Mayer (31) . The consumption of complement in the test samples was expressed as the percentage of the hemolytic complement remaining in a control sample of serum incubated with buffer alone. The function of the alternative pathway of the complement system was determined by measuring the AP50 with rabbit erythrocytes by the method of Takada and Imamura (40) .
Antibodies to lipopolysaccharide. Rabbit antibodies raised against lipopolysaccharide (LPS) extracted and purified from P. aeruginosa P14 were obtained as described by Gonggrijp et al. (14) . In the experiments described, the decomplemented IgG fraction of these rabbit antibodies, prepared by the method of Heide and Schwick (18), was used.
Enzyme-linked immunosorbent assay. The enzyme-linked immunosorbent assay for the detection of human antibodies to LPS and outer membranes (OMs) of the P. aeruginosa strains in serum was performed as described by Gonggrijp et al. (14) .
Determination of proteolytic activity. Proteolytic activity produced by the P. aeruginosa strains in heat-inactivated serum (20%) was assayed with the Azocoll system (Calbiochem, San Diego, Calif.) by the method of Aronson et al. (1).
Preparation and analysis of OMs. OMs of the P. aeruginosa strains PAC 1, P14, and PAC 605 were prepared by the method of Witholt et al. (46) and purified on a discontinuous sucrose gradient as described by Mizumo and Kageyama (35) . Protein was determined by the method of Lowry (29) , with BSA as the standard. 2-Keto-3-deoxyoctonate (KDO) was determined by the thiobarbituric acid method of Weissbach and Hurwicz (45) . NADH oxidase was measured as described by Mizumo and Kageyama (35) . The glucose content of the OM preparations was determined after hydrolysis with 4 M HCl for 4 h at 105°C and subsequent neutralization of the hydrolysate with 2 M NaOH. Glucose was assayed with glucose oxidase, using the GODPerid reagent (Boehringer Mannheim Corp., Mannheim, West Germany). Analysis of the content of total carbohydrate of the 0-chain of LPS was determined after hydrolysis of the OM preparations with 1% (vol/vol) acetic acid for 90 min at 105°C. After centrifugation at 8,000 x g for 15 min to remove liberated lipid A, the supernatant was assayed for hexoses with the anthrone method of Herbert et al. (19) .
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of the OM preparations was performed in a 14% acrylamide gel by the method of Lugtenberg et al. (30) . OM proteins were detected by staining of the gels with Coomassie blue G. For LPS analysis, the OM preparations were incubated with proteinase K (Sigma) (1 ,ug/ml) for 1 h at 60°C before electrophoresis. Detection of LPS was performed by silver staining as described by Tsai and Frasch (42) .
Virulence of P. aeruginosa. Decrease of anti-LPS antibodies attached to the bacterial surface. The decrease of anti-LPS bound to the bacterial surface due to activated complement system was measured as follows. Bacteria were incubated in 20% heat-inactivated absorbed serum supplemented with rabbit IgG anti-LPS antibodies at 37°C for 60 min. Then the washed, opsonized bacteria were incubated in 20% absorbed human serum at 37°C. After certain periods of time the reaction was stopped by the addition of 3 ml of ice-cold PBS-5 mM MgCl2. After three washings, the bacteria were resuspended in 0.5 ml of PBS-5 mM MgCl2. Of this suspension, 100 ,u was incubated with 100 ,u1 of goat-anti rabbit IgG-POD conjugate (Nordic Immunological Laboratories, Tilburg, The Netherlands) in a dilution of 1:200 for 15 min at 25°C. After three washings, the POD activity and the number of bacteria were determined. Additionally, anti-LPS antibodies were detected on the bacterial surface by electron microscopy, using the protein A-gold technique (13) . A 50-,ul portion of a bacterial suspension (5 x 106 per ml) was sedimented on a copper grid (400 mesh, Formvar-coated) by centrifugation (Airfuge; Beckman Instruments, Inc., Palo Alto, Calif.) at 10 lb/in2 for 30 s. Then the grids were fixed with a mixture of 2% paraformaldehyde and 0.2% glutaraldehyde in PBS for 30 min. Excess aldehyde was removed by three washes with PBS for 10 min. The grids were incubated for 30 min at room temperature with a solution of colloidal gold (5 nm)-protein A. To remove unbound gold-protein A, the grids were washed twice with PBS. The density of gold particles on the bacterial surface was determined by examination of the grids with a Philips EM 200 electron microscope. RESULTS C3 fixation, phagocytosis, and complement consumption. For a comparison of C3 fixation and phagocytosis with complement consumption, P. aeruginosa strains and the control strains E. coli F8 and S. aureus 104 were incubated in 20% normal human serum. After 30 min, the amount of hemolytic complement remaining in the mixtures after centrifugation was determined and was compared with the amount of C3 attached on the bacterial surface and with the percentage of phagocytosis of the opsonized bacteria by human PMNs. There was a close correlation between C3 fixation and phagocytosis, but these processes did not correlate with complement consumption in the fluid phase (Table 1) . Statistical analysis of the data revealed that the coefficient of correlation between C3 fixation and phagocytosis was 0.98. To exclude the role of proteolytic enzymes produced by the P. aeruginosa strains, protease production was measured after incubation of the strains in heat-inactivated serum for 30 min. However, proteolytic activity could not be demonstrated; also, cell-associated proteolytic activity was not observed. When the time course of the consumption of hemolytic complement by P. aeruginosa PAC 1 and PAC 605 was followed, it was found that PAC 605 consumed complement only for 20 min, whereas PAC 1 consumed complement at a constant rate for at least 30 min, a rate much higher than that of PAC 605 (Fig.  1) .
CL responses of PMNs to P. aeruginosa. Quantitative measurement of CL, the light emitted by PMNs during phagocytosis, is another technique of potential value in assessing the opsonization of bacteria. The luminol-amplified CL exhibited by human PMNs during phagocytosis of P. aeruginosa strains PAC 1, PAC 605, and P14 is shown in Fig.  2 . The parent strain PAC 1 elicited little response, in contrast to the PAC 605 derivative and strain P14. Since the slope of the CL response appears to be a significant measure of serum opsonic activity (39), the differences in CL responses (Fig. 2) indicated a reflection of difference in the extent of opsonization of the bacteria and correlated closely with C3 fixation and percentage of phagocytosis (Table 1) and P14 were not significantly different (P = 0.1).
Opsonization of P. aeruginosa. Absorption of normal human serum with the corresponding strain revealed that the opsonization of P14 and PAC 1 was strongly dependent on the so-called natural antibodies (Fig. 3) experiments, it was clear that the composition of LPS might play a major role in the opsonization of the P. aeruginosa strains. Analysis of the OMs of P. aeruginosa PAC 1, PAC 605, and P14 revealed that the amount of OM protein and the pattern of sodium dodecyl sulfate-polyacrylamide gel electrophoresis were identical in these strains (data not shown). Also, the amount of KDO with respect to the amount of OM protein did not differ significantly in these strains. However, the amounts of glucose and hexose were rather different ( Table 2) . LPS of PAC 605 did not contain glucose, as was also observed by Koval and Meadow (25) and Meadow et al. (32) . Therefore, it is reasonable to conclude that the number of anchor places on the cell surface for LPS was identical in these strains and that the length of the 0-chains differed considerably (Fig. 4) . Sodium dodecyl sulfate-polyacrylamide gel electrophoresis confirmed that PAC 605 lacked the characteristic multiple bands, representing the heterogenicity of 0-chain lengths in a single strain as was observed in the parent strain PAC 1; strain P14 only lacked the highmolecular-weight polysaccharide bands. These results indicate that LPS of PAC 605 was markedly deficient in 0-polysaccharide side chains and that P14 is an intermediate strain with respect to the length of these side chains.
Decrease of anti-LPS antibodies attached to the bacterial surface caused by the complement system. When the P. aeruginosa strains were opsonized in normal human serum, washed, and incubated with fluorescein isothiocyanateconjugated antibodies specific for human IgG, fluorescence was clearly observed, whereas absorbed sera gave no fluorescence. Enzyme-linked immunosorbent assay techniques also demonstrated the presence of anti-LPS antibodies of the IgG as well as the IgM class in normal human serum. Since these natural antibodies obviously played a role in the C3 fixation of PAC 1 and P14 (Fig. 3) , it was assumed that a high spillage or consumption of complement in the fluid phase could be due to a solubilizing effect of the complement system on the immune complexes formed between the 0-chain of LPS and the anti-LPS antibodies. The influence of the complement system on the release of IgG attached to the bacterial surface was studied (Fig. 5) . P. aeruginosa PAC 1, P14, and PAC 605 were preincubated with heat-inactivated absorbed serum supplemented with IgG anti-LPS antibodies. The washed bacteria were then incubated in absorbed serum, Mg EGTA-absorbed serum, or heat-inactivated serum. It must be noted that sera absorbed with the corresponding strain were used to exclude interference of natural antibodies. Although the initial amounts of IgG attached to the bacterial surface were almost identical (data not shown), the rate of IgG release from PAC 1 was considerably higher than that from PAC 605 and P14. Moreover, heat inactivation of the serum inhibited this release, and the process of release was shown to be mediated by the alternative pathway of complement. When the bound IgG anti-LPS antibodies were measured by the protein A-gold technique, identical results were obtained (data not shown).
DISCUSSION
In the present study, the role of LPS in the opsonization and phagocytosis of P. aeruginosa was investigated. When opsonization of P. aeruginosa PAC 1, PAC 605, and P14 was measured either directly by determination of the amount of C3 attached to the bacterial surface or indirectly by assessment of phagocytosis by human PMNs accompanied by the responses of CL, it was clearly demonstrated that these processes were closely correlated (Table 1 and Fig. 2) . The consumption of complement in the fluid phase, however, gave a completely different picture (Table 1 and Fig. 1 ). Since strain PAC 605 is an 0-chain-deficient mutant of PAC 1 (25, 32) , it was assumed that the 0-chain of LPS played a crucial role in the opsonization of P. aeruginosa. Various authors have reported that differences not only in the length but also in the structure of the 0-chain of LPS affect complement activation (15, 26, 28, 41) . It is generally accepted that the polysaccharide portion of LPS is responsible for alternative pathway activation, whereas lipid A activates complement via the classical pathway in the absence of antibodies to LPS (2, 3, 6, 21, 36) . Both pathways result in formation of C5b-9 complexes, but whereas 0-chaindeficient bacteria are readily lysed in serum, bacteria with an 0-chain resist serum killing, presumably by shedding the C5b-9 complexes that attach to them, even in the presence of antibodies (22) (23) (24) . Consequently, the latter strains are more virulent than strains lacking the 0-chain of LPS (7, 17, (26) (27) (28) .
In this study, it was also shown that with respect to strains PAC 1 and PAC 605, the lack of an 0-side chain resulted in increased sensitivity to serum and decreased virulence. Moreover, PAC 605 could be effectively opsonized by C3 in the presence or absence of antibodies in both the classical and alternative pathways of complement. Since PAC 605 possesses only a core plus lipid part of LPS (25, 32) , it is remarkable that this strain was opsonized by C3 to almost the same extent by both complement pathways. Therefore, it cannot be excluded that complement activation by PAC 605 was due not to the deficient LPS but to other components of the OM such as OM proteins (see reference 21). On the other hand, it was clear that the opsonization of PAC 1 and P14, both possessing an LPS 0-chain, was strongly dependent on the presence of natural or immune antibodies to LPS, even when only the alternative pathway of complement was functional. Moreover, the opsonization of PAC 1 and P14 was less effective in Mg EGTA serum (Fig. 3) . Thus, it was of interest why PAC 1 was less opsonized by C3 and consumed more complement in the fluid phase compared with P14. First, it was shown that PAC 1 and P14 had an identical amount of anchor places of LPS, but that LPS of P14 contained shorter lengths of 0-chains than did LPS of PAC 1 (Table 2 and Fig. 4) . Second, when the release of specific immune antibodies attached to the bacterial surface by the complement system was studied, it could be demonstrated that these antibodies were rapidly released from PAC 1, preferentially by the alternative pathway (Fig. 5) complexed to IgG is significantly more effective in alternative pathway consumption of serum C3 than is free fluidphase C3b. As a consequence, PAC 1 could become less opsonized by C3b and IgG, resulting in diminished phagocytosis and CL during phagocytosis. Alternatively, the dissociation between complement consumption and C3 binding by PAC 1 might represent inefficient binding of C3 which has been cleaved to C3b by a bacteria-bound convertase. However, no actual data are available to demonstrate such a dissociation between C3 consumption and binding for PAC 1. It is remarkable that in the case of P14, neither loss of bound IgG due to the alternative pathway of complement, nor a high consumption of complement in the fluid phase, was observed. Whatever the precise mechanism of the diminished C3 fixation of PAC 1, both in vivo and in vitro experiments strongly suggested that the structure of the 0-antigen polysaccharide side chain of LPS is of crucial importance for evasion of host defense mechanisms by P. aeruginosa.
